Mind MedicineÂ Inc (MNMD)

Name: Mind MedicineÂ Inc (MNMD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Mind MedicineÂ Inc (MNMD)

Stock Card

$15.75

$0.37 (2.41%)

As on 13-Feb-2026 09:30EDT

Market cap

$1,460 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

12.9

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Mind MedicineÂ Inc (MNMD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 15.62 High: 16.65

52 Week Range

Low: 4.70 High: 16.65

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.9 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-6.6
Debt to Equity

0.3
Book Value

$--
EPS

$-2
Face value

--
Shares outstanding

97,219,193

7 Years Aggregate

CFO

$-185.63 Mln

EBITDA

$-291.57 Mln

Net Profit

$-273.50 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Mind MedicineÂ Inc (MNMD)	17.6	13.5	29.7	85.1	60.8	-23.5	--
BSE Sensex^*	-9.8	-2.2	2.9	-4.9	5.3	5.9	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 13-Feb-2026 | *As on 02-Sep-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021	2020	2019
Mind MedicineÂ Inc (MNMD)	92.4	66.4	-89.4	-54.8	573.7	26.9
S&P Small-Cap 600	4.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Mind MedicineÂ Inc (MNMD)	15.8	1,460.2	0.0	-168.1	--	-95.1	--	12.9
Bright Minds Biosciences Inc (DRUG)	70.8	714.4	0.0	-24.8	--	-12.4	--	3.3
Cybin (CYBN)	5.2	413.1	0.0	-131.6	--	-61.8	--	1.0
Flora Growth (FLGC)	9.6	5.8	14.5	-4.4	-28.0	-11.8	--	0.3
Oncolytics Biotech - ADR	0.8	109.2	0.0	-38.2	--	--	--	1,055.0

Shareholding Pattern

View Details

About Mind MedicineÂ Inc (MNMD)

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety... disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York. Read more

CEO & Director

Mr. Robert Barrow
CEO & Director

Mr. Robert Barrow
Headquarters

New York, NY
Website

https://www.mindmed.co

FAQs for Mind MedicineÂ Inc (MNMD)

What is the current share price of Mind MedicineÂ Inc (MNMD) Today?

The share price of Mind MedicineÂ Inc (MNMD) is $15.75 (NASDAQ) as of 13-Feb-2026 09:30 EDT. Mind MedicineÂ Inc (MNMD) has given a return of 60.77% in the last 3 years.

What is the current PB & PE ratio of Mind MedicineÂ Inc (MNMD)?

Since, TTM earnings of Mind MedicineÂ Inc (MNMD) is negative, P/E ratio is not available.
The P/B ratio of Mind MedicineÂ Inc (MNMD) is 12.91 times as on 13-Feb-2026, a 321 premium to its peers’ median range of 3.07 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	-5.38	2.42
2023	-1.54	1.89
2022	-1.47	0.55
2021	-0.42	0.26
2020	-2.32	1.04

What is the 52 Week High and Low of Mind MedicineÂ Inc (MNMD)?

The 52-week high and low of Mind MedicineÂ Inc (MNMD) are Rs 16.65 and Rs 4.70 as of 02-Sep-2026.

What is the market cap of Mind MedicineÂ Inc (MNMD)?

Mind MedicineÂ Inc (MNMD) has a market capitalisation of $ 1,460 Mln as on 13-Feb-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Mind MedicineÂ Inc (MNMD)?

Before investing in Mind MedicineÂ Inc (MNMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.